EUVIMEDEUVIMED entdecken
Crossref

Structural Changes at the Zinc Active Site of ACE2 on Binding the SARS-CoV-2 Spike Protein Receptor Binding Domain

Natalia V Dolgova, Muhammad Qureshi, Matthew Latimer, Andrey Grishin, Miroslaw Cygler iD, Linda I Vogt, Julien J H Cotelesage, Dimosthenis Sokaras iD, Thomas Kroll iD, Ingrid J Pickering iD, Graham N George iD

Inorganic Chemistry · 2025

DOI: 10.1021/acs.inorgchem.4c04974 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inorganic Chemistry, 2025. Verfasst von Natalia V Dolgova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Calibr─California Institute for Biomedical Research, Scripps Research, 11119 North Torrey Pines Road, La Jolla, California 92037, United States. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme 2, Zinc, Spike Glycoprotein, Coronavirus, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Canadian Institutes of Health Research, Social Sciences and Humanities Research Council of Canada, Canada Research Chairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The causative agent of Covid-19 is the SARS-CoV-2 virus. Initiation of cell entry by SARS-CoV-2 is critically dependent upon binding of the SARS-CoV-2 spike protein to angiotensin-converting enzyme 2 (ACE2, EC 3.4.17.23). The mechanism of binding of the SARS-CoV-2 spike receptor binding domain to ACE2 is among the most intensively studied infection mechanisms of any pathogen, including a very large number of structural studies. ACE2 is a membrane-associated zinc carboxypeptidase, comprising three domains, the protease domain, a neck domain, and a membrane-spanning α-helical domain. In addition to its role as a carboxypeptidase, ACE2 is also a chaperone for a Na+-amino acid cotransporter called B0AT1, and in the presence of B0AT1, full-length ACE2 forms dimers. Most studies to date related to Covid-19 have employed just the ACE2 protease domain and have neglected any possible roles of the Zn2+-containing ACE2 active site. We show here that ACE2, including the neck domain in addition to the protease domain (and in the absence of B0AT1), is dimeric and shows distinctive allostery in its catalytic activity. In contrast, the intensively studied protease domain is monomeric and shows no allostery. Binding of the spike receptor binding domain (RBD) to dimeric ACE2 eliminates its allostery. X-ray absorption spectroscopy of Zn2+ ACE2 shows distinctive changes in the active site structure upon binding of spike RBD but only in the dimeric form. Taken together, our results indicate that the Zn2+-containing active site exhibits a notable level of flexibility and that the dimeric form of ACE2, including both protease and neck domains, likely presents a superior model for the study of ACE2-spike interactions than the monomeric ACE2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin-Converting Enzyme 2ZincSpike Glycoprotein, CoronavirusSARS-CoV-2HumansCatalytic DomainProtein BindingProtein DomainsBinding SitesCOVID-19

Substanzen

Angiotensin-Converting Enzyme 2ZincSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2ACE2 protein, human

Autor:innen und Institutionen

  • Calibr─California Institute for Biomedical Research, Scripps Research, 11119 North Torrey Pines Road, La Jolla, California 92037, United States.
  • Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, Stanford University, Menlo Park, California 94025, United States.
  • Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan, 110 Science Place, Saskatoon, Saskatchewan S7N 5C9, Canada.
  • Department of Geological Sciences, University of Saskatchewan, 114 Science Place, Saskatoon, Saskatchewan S7N 5E2, Canada.
  • Toxicology Centre, University of Saskatchewan, 44 Campus Drive, Saskatoon, Saskatchewan S7N 5B3, Canada.
  • Department of Chemistry, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5C9, Canada.

ORCID-Profile: Miroslaw Cygler, Dimosthenis Sokaras, Thomas Kroll, Ingrid J Pickering, Graham N George

Förderung

  • Canadian Institutes of Health Research
  • Social Sciences and Humanities Research Council of Canada
  • Canada Research Chairs
  • Natural Sciences and Engineering Research Council of Canada
  • Chevron

Zitieren

APA

Dolgova, N. V., Qureshi, M., Latimer, M., Grishin, A., Cygler, M., Vogt, L. I., Cotelesage, J. J. H., Sokaras, D., Kroll, T., Pickering, I. J., & George, G. N. (2025). Structural Changes at the Zinc Active Site of ACE2 on Binding the SARS-CoV-2 Spike Protein Receptor Binding Domain. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.4c04974

Vancouver

Dolgova NV, Qureshi M, Latimer M, Grishin A, Cygler M, Vogt LI, et al. Structural Changes at the Zinc Active Site of ACE2 on Binding the SARS-CoV-2 Spike Protein Receptor Binding Domain. Inorganic Chemistry. 2025. doi:10.1021/acs.inorgchem.4c04974

BibTeX
@article{Dolgova2025,
  author = {Dolgova, Natalia V and Qureshi, Muhammad and Latimer, Matthew and Grishin, Andrey and Cygler, Miroslaw and Vogt, Linda I and Cotelesage, Julien J H and Sokaras, Dimosthenis and Kroll, Thomas and Pickering, Ingrid J and George, Graham N},
  title = {Structural Changes at the Zinc Active Site of ACE2 on Binding the SARS-CoV-2 Spike Protein Receptor Binding Domain},
  journal = {Inorganic Chemistry},
  year = {2025},
  doi = {10.1021/acs.inorgchem.4c04974}
}
Kostenlos starten →